Cadila Healthcare Q2 PAT may dip 23% YoY to Rs. 321.5 cr: Emkay

Emkay has come out with its second quarter (July-September’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Cadila Healthcare to report net profit at Rs. 321.5 crore down 23% year-on-year (up 6% quarter-on-quarter).

Net Sales are expected to increase by 17.4 percent Y-o-Y (down 0.6 percent Q-o-Q) to Rs. 3,475.2 crore, according to Emkay.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 5 percent Y-o-Y (up 4 percent Q-o-Q) to Rs. 655.6 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.